| Name | Bcl-2-IN-11 |
|---|
| Description | Bcl-2-IN-11 (compound 6) is a potent and selective Bcl-2 activity inhibitor, with an IC50 of 0.9 nM. Bcl-2-IN-11 shows weak inhibition of Bcl-xl (IC50 > 1000 nM). Bcl-2-IN-11 can be used for the research of a variety of cancers caused by abnormal overexpression of Bcl-2 family proteins: especially malignant hematologic diseases of acute lymphoid leukemia, etc. Bcl-2-IN-11 can also avoid toxic side effects caused by Bcl-xl inhibition, such as thrombocytopenia[1]. |
|---|---|
| Related Catalog | |
| Target |
Bcl-2:0.9 nM (IC50) Bcl-xL:>1000 nM (IC50) |
| References |
[1]. Kong Xianglong, et al. Heterocyclic compound as bcl-2 inhibitor. WO2022028353A1. |
| Molecular Formula | C45H49ClFN7O8S |
|---|---|
| Molecular Weight | 902.43 |